Loading company…
Microbiome researches and develops microbiome-based products for health, beauty, and food applications.
Microbiome researches and develops pharmaceutical, beauty, and alternative food products, with work on materials addressing metabolic diseases, immune health, colorectal cancer, and other healthcare and cosmetic needs. The company is based in Seoul, South Korea, and was founded in 2017. In May 2022, it raised KRW 2 billion in Series A funding led by New Paradigm Investment, with participation from KAIC and KMU Holdings.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in